AXSM vs COP · rev $409.6M vs P/E 19, rev $34.92B
Axsome Therapeutics Inc (AXSM) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported COP revenue for 2026-06-30 was $34.92B. Net income was $6.11B. COP currently screens at market cap $135.49B and trailing P/E 18.8.
AXSM currently screens at market cap $11.96B. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the AXSM and COP stock pages for the full models.
Not investment advice.